A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
Public ClinicalTrials.gov record NCT05953480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS). This study consists of 2 cohorts, Cohort A and Cohort B. Cohort A (redasemtide or placebo) will enroll participants who are ineligible for systemic thrombolysis and/or mechanical recanalization therapy. Cohort B (redasemtide or placebo) will enroll participants who are eligible to receive or who have received systemic thrombolysis and/or mechanical recanalization therapy as standard of care.
Study identification
- NCT ID
- NCT05953480
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2023 (Actual)
- Primary completion
- Jun 15, 2026 (Actual)
- Completion
- Jun 15, 2026 (Actual)
- Last update posted
- Jul 30, 2026
2023 – 2026
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University of Arizona Medical Center | Tucson | Arizona | 85724 | — |
| Intercoastal Medical Group | Sarasota | Florida | 34239-3228 | — |
| Augusta University | Augusta | Georgia | 30912-0004 | — |
| Mercyhealth Javon Bea Hospital- Riverside | Rockford | Illinois | 61114-2300 | — |
| Community Hospital | Munster | Indiana | 46321-2901 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215-5216 | — |
| Munson Healthcare | Traverse City | Michigan | 49684 | — |
| Mayo Clinic Hospital-Rochester, St. Mary's Campus - PPDS | Rochester | Minnesota | 55905-0001 | — |
| North Shore University Hospital-300 Community Dr | Manhasset | New York | 11030-3816 | — |
| Nuvance Health Medical Practice, PC- Neurosurgery | Poughkeepsie | New York | 12601-3986 | — |
| Summa Health System - Akron Campus | Akron | Ohio | 44304 | — |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210-1240 | — |
| Ascension St. John Clinical Research Institute | Tulsa | Oklahoma | 74104-5437 | — |
| Baylor University Medical Center - 3500 Gaston Ave | Dallas | Texas | 75246 | — |
| Houston Methodist Hospital | Houston | Texas | 77030-2726 | — |
| Baylor Scott & White - Plano Brain & Spine Center | Plano | Texas | 75093-5338 | — |
| University Health-University Hospital | San Antonio | Texas | 78229-3931 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05953480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05953480 live on ClinicalTrials.gov.